[Hair Loss Peptide](/)

[What the hair studies can actually tell us](/ghk-cu)

[How to take a hair concern to a clinician](/safety-and-care)

[About](/about)

[Home](/) / Other peptides

# Similar peptide names can hide very different studies.

Once you’ve looked up one peptide, several more names tend to follow. We keep them separate here. Sharing a few letters, or even copper, doesn’t let one ingredient borrow another’s results. What happened in the experiment matters as much as what went into it.

## A follicle outside the scalp is still a lab finding

![Illustrative microscopy view of isolated hair follicles with attached hair fibres.](/scalp-paper-a3e549d8fa39/looking-closely-at-a-hair-sample.webp)

An illustrative view of hair follicles outside the scalp, rather than a treatment result.

AHK-Cu is a copper peptide, but it isn’t GHK-Cu with a spelling mistake. In [a study of isolated human hair follicles and cells](https://pubmed.ncbi.nlm.nih.gov/17703734/), researchers reported hair growth in follicles kept outside the body. Follicles are the structures hairs grow from.

That’s a lab finding. The word ‘human’ tells us where the tissue came from. It doesn’t mean the researchers treated people or established a safe way to use AHK-Cu for hair loss.

We’d leave the finding attached to AHK-Cu, too. It can’t answer whether GHK-Cu works on someone’s scalp. A related ingredient can be a reason for more research without supplying the missing answer.

## Zinc-thymulin has an early report in people

A [pilot study explored zinc-thymulin on the scalp](https://doi.org/10.4172/2167-0951.1000147) in adults with pattern hair loss. It was open-label: the people taking part and the researchers knew what was being used. That’s useful context when reading an early report.

The report described it as well tolerated. A small early report can’t settle safety or show how much benefit someone could expect. Thymulin isn’t FDA-approved, and the human research is sparse. There’s no established routine to offer here.

Thymulin, thymosin alpha-1 and thymalin are different substances, despite the similar names. Research on one can’t stand in for research on another. It’s worth checking the exact name when a claim sends you looking for a paper.

## A longer ingredient list isn’t more proof

A mixture needs evidence for that mixture. Separate studies of its ingredients can’t tell us how they’ll work together, or which one explains a change. We’d look for research on the actual combination in people with the relevant kind of hair loss.

The [small GHK-combination trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/) is a useful example. It tested that lotion, rather than every mixture containing a peptide. A dermatologist or licensed clinician can help put the hair concern first and discuss care, including FDA-approved options where they exist. There’s room to be curious without deciding that a peptide has to be the answer.

The [GHK-Cu page](/ghk-cu) looks more closely at copper-peptide research. [Safety and care](/safety-and-care) covers questions about injections, cosmetics and medical care.

Hair Loss Peptide is a guide for hair questions, where we explain the reading without providing clinical care, pharmacy services or sales.

[References](/references) · [Other peptides](/other-peptides) · [The hair question](/hair-loss) · [Contact](/contact)

© 2026 Hair Loss Peptide